openPR Logo
Press release

The COVID-19 Therapeutics Market Research Report 2021| Key Player: Celltrion Healthcare Co.,Ltd.,GSK, Merck, AstraZeneca, Regeneron, Roche, and Many More

08-27-2021 10:29 PM CET | Health & Medicine

Press release from: InsightAce Analytic Pvt. Ltd

The COVID-19 Therapeutics Market Research Report 2021| Key

InsightAce Analytic Pvt. Ltd. announces the market assessment report on “Global COVID-19 Therapeutics Market– By Trends, Industry Competition Analysis, Clinical Trial/Pipeline Analysis, Revenue and Forecast Till 2030.”

Request for Sample Pages: https://www.insightaceanalytic.com/report/global-covid-19-therapeutics-market/1184

According to the latest market intelligence report by InsightAce Analytic, the global COVID-19 therapeutics market size is valued at US$ 5.26 Billion in 2020, and it is expected to reach US$ 25.6 Billion in 2030, recording a promising CAGR of 10.7% from 2021 to 2030.

The COVID-19 virus causes respiratory illness in humans. It may cause severe disease in the geriatric population (Mainly those with diabetes, chronic respiratory disease, cardiovascular disease, and cancer). The increasing outbreak of covid-19 is increasing the demand for coronavirus vaccines, which will result in an expansion of the COVID-19 therapeutics market over the forecast period. According to the WHO (World Health Organization), globally, 175,847,347 confirmed cases of COVID-19, including 3,807,276 deaths, were reported to WHO as of June 15, 2021. Covid-19 cases are increasing day by day, and there is no officially approved drug for COVID-19. Currently, to check the safety and effectiveness of COVID-19 therapeutics, many drug therapies are going through the processes of clinical trials and validations, causing a delay in the drug development process. Many countries are facing a shortage of drugs likely to offer growth opportunities for pharmaceutical drug manufacturers. Leading market players are also making efforts to develop innovative and efficient covid-19 drug therapies, resulting in overall market growth.

Major factors responsible for the growth of the COVID-19 therapeutic market are the fast adoption of advanced technologies, the growing number of corona patients, increasing healthcare expenditures, rising awareness about coronavirus, and increasing efforts by the pharmaceutical companies to develop covid-19 therapeutic drugs. For instance, Eli Lilly and Company is donating COVID-19 therapies to Direct Relief, enabling the humanitarian organization to provide COVID-19 treatments at no cost to low- and lower-middle-income countries most heavily impacted by the pandemic. Furthermore, increasing research investments for the R&D of covid-19 therapeutic drugs is anticipated to drive market growth in the future. However, the high cost required to validate therapies and long-term clinical trials limit the COVID-19 therapeutics market growth.

During the forecast period 2020-2030, North America COVID-19 therapeutic market is expected to dominate the COVID-19 therapeutics market, owing to advancement of technologies, growing awareness about coronavirus, rising government initiatives for R&D of covid-19 vaccines, and an increasing number of market players in this Region. On the other hand, the European region will also hold the largest share of this market during the forecast years due to rising government initiatives in R&D and increasing demand for covid-19 treatment options. Furthermore, Asia Pacific COVID-19 therapeutic market is estimated to be the fastest-growing regional market in the future, attributed to the increasing number of corona patients, rising awareness about the covid treatment options and healthcare facilities, and entry of new players in the market.

Request for ToC/Proposal: https://www.insightaceanalytic.com/report/global-covid-19-therapeutics-market/1184

Some of the key Players of COVID-19 therapeutics market are Atea Pharmaceuticals, Inc., CytoDyn, Celltrion, Eli Lilly and Company, NRX Pharmaceuticals, Shanghai Junshi Biosciences Co., Ltd., Veru Inc., Humanigen, Inc., Catalent, Inc., Cipla Limited, Molecular Partners AG, Merck, Novartis International AG, Regeneron Pharmaceuticals, Inc., Vir Biotechnology, Revive Therapeutics Ltd., Brii Biosciences Limited, GlaxoSmithKline plc, APEIRON Biologics AG, Bristol Myers Squibb, Janssen Pharmaceuticals, Trevena Inc, Ono Pharmaceutical Co., Ltd., Constant Therapeutics LLC, Amarin Corporation plc, FUJIFILM Toyama Chemical Co., Ltd., NeuroBo Pharmaceuticals, Inc., Innovation Pharmaceuticals Inc., Bellerophon Therapeutics, Sorrento Therapeutics, PhaseBio, Pfizer, Takeda, BioAegis Therapeutics, Roivant Sciences, A.I. Therapeutics, Inc., Celltex Therapeutics, Blade Therapeutics, Marinomed Biotech AG, Synairgen, SAb Biotherapeutics, Romark Laboratories, L.C., Kiniksa Pharmaceuticals, UNION therapeutics A/S, Fulcrum Therapeutics, and Other Prominent Players.
On June 1, 2021, NRx Pharmaceuticals announced that it had filed an application with U.S. FDA (Food and Drug Administration) requesting EUA (Emergency Use Authorization) for ZYESAMI (Aviptadil-acetate) to Treat Critically Ill COVID-19 patients suffering from respiratory failure. In addition, in May 2021, NRx Pharmaceuticals, Inc. (NRXP) announced that it signed a master services agreement to perform Phase 3 clinical trials of COVID-19 drugs and vaccines in Central Europe and the Caucasus Region.
In April 2021, Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that the first patient had been dosed in the Phase 3 MORNINGSKY trial, a global multicenter trial evaluating AT-527 in moderate or mild COVID-19 patients in an outpatient setting.
In April 2021, CytoDyn Filed New Protocol with U.S. FDA for 4 Doses of Leronlimab for Critically Ill COVID-19 Patients with the Objective to Duplicate or Surpass 82% Survival Benefit with P-Value of 0.0233 Originally Achieved from Two Weeks of Treatment in CD12 Trial With 2 Doses.

Curious about this latest version of report? Obtain Report Details @https://www.insightaceanalytic.com/report/global-covid-19-therapeutics-market/1184

The Global COVID-19 therapeutic Market Segments

The Global COVID-19 therapeutic Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Drug Class
• Monoclonal Antibodies
• Antiviral
• Anticoagulant
• Glucocorticoid
• Nitric oxide
• Other Drug Class

The Global COVID-19 therapeutic Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Infection Type
• HCoV-229E
• HCoV-OC43
• SARS-CoV
• New Haven CoV
• HKU1-CoV
• MERS-CoV
• Other Infection Types

The Global COVID-19 therapeutic Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America COVID-19 therapeutics market revenue (US$ Million) by Country, 2020 to 2030
• U.S.
• Canada
Europe COVID-19 therapeutics market revenue (US$ Million) by Country, 2020 to 2030
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific COVID-19 therapeutics market revenue (US$ Million) by Country, 2020 to 2030
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America COVID-19 therapeutics market revenue (US$ Million) by Country, 2020 to 2030
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa COVID-19 therapeutics market revenue (US$ Million) by Country, 2020 to 2030
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
- To receive a comprehensive analysis of the prospects for global COVID-19 therapeutics market
- To receive industry overview and future trends of COVID-19 therapeutics market
- To analyse the COVID-19 therapeutics market drivers and challenges
- To get information on COVID-19 therapeutics market size value (US$ Mn) forecast till 2030
- Major Investments, Mergers & Acquisition in COVID-19 therapeutics market industry

For More Information @ https://www.insightaceanalytic.com/report/global-covid-19-therapeutics-market/1184

InsightAce Analytic Pvt.Ltd, Office No.3050, 3rd Floor Marvel Fuego, Magarpatta Rd, Hadapsar, Pune, Maharashtra 411028.

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact U.S.:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The COVID-19 Therapeutics Market Research Report 2021| Key Player: Celltrion Healthcare Co.,Ltd.,GSK, Merck, AstraZeneca, Regeneron, Roche, and Many More here

News-ID: 2371842 • Views:

More Releases from InsightAce Analytic Pvt. Ltd

Veterinary Infectious Disease Diagnostics Market Advancements Highlighted by Growth and Restrain Factors Analysis Report
Veterinary Infectious Disease Diagnostics Market Advancements Highlighted by Gro …
"Veterinary Infectious Disease Diagnostics Market" in terms of revenue was estimated to be worth $2.06 billion in 2023 and is poised to reach $3.95 billion by 2031, growing at a CAGR of 3.95% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1488 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the veterinary infectious disease diagnostics market are: • Rising rates of zoonotic
Manuka Honey Market Know the Scope and Trends Revealed In New Report
Manuka Honey Market Know the Scope and Trends Revealed In New Report
"Manuka Honey Market" in terms of revenue was estimated to be worth $483.31 Mn in 2023 and is poised to reach $729.63 Mn by 2031, growing at a CAGR of 5.43% from 2024 to 2031, according to a new report by InsightAce Analytic. Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1554 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global Manuka Honey Market are: · Health
Geospatial Analytics Market Report Explores the Exclusive Report with Detailed Study Analysis
Geospatial Analytics Market Report Explores the Exclusive Report with Detailed S …
"Geospatial Analytics Market" in terms of revenue was estimated to be worth $74.83 billion in 2023 and is poised to reach $191.61 billion by 2031, growing at a CAGR of 12.72% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1641 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global Geospatial Analytics Market are: • Increasing Adoption of Location-Based Services (LBS) • Growing Awareness of
Alcoholic Energy Drinks Market Current Scenario with Future Aspect Analysis
Alcoholic Energy Drinks Market Current Scenario with Future Aspect Analysis
"Alcoholic Energy Drinks Market" in terms of revenue was estimated to be worth $27.92 billion in 2023 and is poised to reach $49.20 billion by 2031, growing at a CAGR of 7.50% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1531 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global Alcoholic Energy Drinks Market are: • Increasing consumer demand for innovative beverage

All 5 Releases


More Releases for Therapeutics

Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant
Pruritus Drug Market – Key Players are Cara Therapeutics, Enteris BioPharma, N …
The Pruritus Drug Market research report is a significant investigation of changing business sector elements, driving elements, impediments, and limitations that have been considered the most extensive impacts on market development. Adroit investigative devices, for example, Porter’s Five Forces examination, SWOT examination, and Feasibility examination study have likewise been utilized by the report to offer an exhaustive information of the market. It will go about as a key research report
Dravet Syndrome Therapeutics- Pipeline Analysis 2018 | Zogenix, Inc., Ovid Thera …
Dravet syndrome is a form of severe myoclonic epilepsy that occurs in infants during their first year of age. If left untreated, it can be associated with other types of seizures, and status epilepticus. Children having Dravet syndrome are generally observed with poor cognitive skills and hyperactivity. Download the sample report @ https://www.pharmaproff.com/request-sample/1098 It severely affects the person’s quality of life and around 10-20% of the patient are estimated to die due
Global mRNA Cancer Vaccines and Therapeutics Market to 2025| Moderna Therapeutic …
Researchmoz added Most up-to-date research on "Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2019-2025" to its huge collection of research reports. mRNA Cancer Vaccines and Therapeutics Market report includes (6 Year Forecast 2019-2025) includes Overview, classification, industry value, price, cost and gross profit. It also offers in-intensity insight of the mRNA Cancer Vaccines and Therapeutics industry masking all vital parameters along with, Drivers, Market Trends, Market Dynamics,
Global Pruritus Therapeutics Market Report 2019 Companies included Actavis, Trev …
Market Reports Company has recently published 7th edition of Pruritus Therapeutics Market Report which covers historic data of year 2013 to 2018 along with a forecast till year 2026. For inquiry or free sample pages email us at: sales@marketreportscompany.com The report provides a comprehensive view on the current state and future prospects of the market which analyzes different strategies for business growth. The global Pruritus Therapeutics market was valued at USD xx
MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Mode …
WiseGuyReports.Com Publish a New Market Research Report On –“ MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics”. Description:- The mRNA Vaccines & Therapeutics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, mRNA Vaccines & Therapeutics market size to maintain the average annual growth rate of XXX from